OncoCyte Corp <OCX.OQ> expected to post a loss of 43 cents a share - Earnings Preview
OncoCyte Corp OCX.OQ OCX.O is expected to show a fall in quarterly revenue when it reports results on March 24 for the period ending December 31 2024
The Irvine California-based company is expected to report a 68.2% decrease in revenue to $100 thousand from $314 thousand a year ago, according to the mean estimate from 2 analysts, based on LSEG data.
LSEG's mean analyst estimate for OncoCyte Corp is for a loss of 43 cents per share.
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for OncoCyte Corp is $4.13, above its last closing price of $3.40.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.44 | -0.44 | -0.98 | Missed | -124.8 |
Jun. 30 2024 | -0.55 | -0.56 | -0.36 | Beat | 35.6 |
Mar. 31 2024 | -0.65 | -0.67 | -1.13 | Missed | -69.1 |
Dec. 31 2023 | -1.14 | -2.12 | Missed | -86.5 | |
Sep. 30 2023 | -1.00 | -1.01 | -0.81 | Beat | 19.6 |
Jun. 30 2023 | -0.68 | -1.30 | -1.07 | Beat | 17.7 |
Mar. 31 2023 | -1.31 | -1.84 | 0.40 | Beat | 121.7 |
Dec. 31 2022 | -1.88 | -8.00 | Missed | -324.6 |
This summary was machine generated March 21 at 23:02 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
This $1 Trillion AI Stock Is Getting Ready for 2026: Is Meta a Good Buy?
When ads and commerce are factored in, Meta is building a long-term platform—in Augmented Reality and smart glasses — to get us closer to the future of AI. This device hardware business is less profitable than ads right now, but it could grow the company’s ecosystem and open up new ways for it to ma
Is SaaS Dead? The Truth Behind the Software Meltdown, the Missing Floor, and the Peak That’s Not Coming Back
TradingKey - A trillion dollars just vanished from software stocks—this piece breaks down who AI is really killing, who quietly benefits, and why cheap SaaS may be the biggest value trap of this cycle.
Best AI Tools for Stock Analysis in 2026 to Boost Your Investment Portfolio
As Artificial Intelligence (AI) continues to enhance everyday decision-making, these tools will allow us to leverage artificial intelligence to analyse stocks and optimise our investment portfolio.
Silver Faces Sixth Consecutive Year of Supply Deficit, How Much Upside Is Left in 2026?
TradingKey - According to the 2026 Silver Market Outlook recently released by the Silver Institute, the current robust performance of the silver market remains supported by solid fundamentals. The report indicates that the global silver market is expected to face a structural supply-demand imbalance
